Greiner Bio-One GmbH, internationally leading technology partners to the diagnostic and pharmaceutical industry, and the French company CellMade are jointly publishing a new catalogue for products and solutions from the field of cell based research.
The cooperation contract provides for the large-scale supply of human primary cells and stem cells, as well as media and reagents, by CellMade. Greiner Bio-One GmbH will distribute these items together with their own products. Hence Greiner Bio-One can in future offer their customers not only laboratory articles, but also cells and the associated media.
CellMade spokesman Ronald Bronsaer emphasises: “The linking of the two product portfo-lios from CellMade and Greiner Bio-One opens up highly interesting new opportunities, above all with regard to co-culture models. Greiner Bio-One’s products and technologies and ours obviously complement one another very well. We can now build on our common experiences in the field of cell biology.”
“Greiner Bio-One’s products and technologies are very widespread in laboratory research into cell biology. The cooperation with CellMade will strengthen our market position even further,” explains Heinz Schmid, Managing Director of Greiner Bio-One GmbH. “Our cus-tomers will benefit significantly from the enlarged portfolio. Not only that, we expect that the cooperation will have a positive economical effect as early as 2007.”